[421]
PO529 RESIDUAL TUMOR RESECTION (RTR) IN ADVANCED TESTICULAR CANCER ...
From [www.kukm.de] Last viewed: 02.07.2005
[422]
PO528 REPEAT RETROPERITONEAL LYMPH NODE DISSECTION FOR ADVANCED ...
From [www.kukm.de] Last viewed: 02.07.2005
[423]
TESTICULAR CANCER - All Sections
From [pivnik.ru] Last viewed: 02.07.2005
[424]
072497 Testicular Germ-Cell Cancer
From [pivnik.ru] Last viewed: 02.07.2005
[425]
072497 Testicular Germ-Cell Cancer
From [pivnik.ru] Last viewed: 02.07.2005
[426]
How to check for Testicular Cancer
From [24.188.204.172] Last viewed: 02.07.2005
[427]
Testicular Cancer
[41,8 KB]
From [www.preventcancer.org] Last viewed: 28.05.2005
Testicular Cancer
In 2005, an estimated 8,010 males will be diagnosed with testicular cancer . When found
early, testicular cancer is one of the most treatable forms of cancer , with an overall cure
rate above 90 percent.
PREVENTION
• Talk to your health care professional about screening.
RISK
• All men
• Men with a history of cryptorchidism — testicle(s) that have not descended
• Men with a personal or family history of testicular cancer
• Caucasian men are at higher risk
SYMPTOMS
Most testicular cancer can be found at an early stage. Some of the symptoms that may
appear include:
• A lump on either testicle
• Enlargement of either testicle
• Heaviness or aching in the lower abdomen or scrotum
• Pain or discomfort in a testicle or in the scrotum
• A collection of fluid in the scrotum
• Breast growth or tenderness ...
[428]
Stem-Cell Transplant for Testicular Cancer
[311,7 KB]
From [www.cigna.com] Last viewed: 28.05.2005
C
IGNA
H
EALTH
C
ARE
C
OVERAGE
P
OSITION
Subject
Stem-Cell Transplant for
Testicular Cancer
Effective Date.4/15/2005
Coverage Position Number . 0323
Table of Contents
Related Coverage Positions
Coverage Position..1
General Background .1
Coding/Billing Information..5
References.6
Appendix: Disease Classifications and Stages7
INSTRUCTIONS FOR USE
Coverage Positions are intended to supplement certain standard CIGNA HealthCare benefit plans. Please note, the terms of a
participant’s particular benefit plan document [Group Service Agreement (GSA), Evidence of Coverage, Certificate of Coverage,
Summary Plan Description (SPD) or similar plan document] may differ significantly from the standard benefit plans upon which
these Coverage ...
[429]
about testicular cancer
[1274,7 KB]
From [www.nfcr.org] Last viewed: 28.05.2005
research for a cure
laboratory without walls
National Foundation for Cancer Research
Cancer FAQs
about testicular cancer
Frequently Asked Questions about common cancers.
Page 2
Cancer FAQs
What are the different types of testicular cancer ?
There are many different forms of testicular cancer , but most types begin
in immature cells called germ cells, which develop into sperm. The two
main types of germ cell tumors are seminomas and nonseminomas. Many
testicular tumors have features of both forms.
The various types of testicular cancers differ in their prognosis (survival
outlook) and in the ways they are treated. Seminomas are the most curable
of testicular cancers, as they grow very slowly and do not spread to other
parts of the body. They account for about 30 percent of all testicular ...
[430]
Surviving Testicular Cancer
[254,0 KB]
From [dissertations.ub.rug.nl] Last viewed: 28.05.2005
Targeted destruction of prostate, breast, ovarian, and testicular
cancer cells through their LH/CG receptors
William Hansel and Carola Leuschner
Pennington Biomedical Research Center, Louisiana State University, Baton
Rouge, LA, 70808
In a series of in vitro and in vivo experiments involving 1630 nude mice, the
concept has been established that prostate, breast, ovarian and testicular cancer
cells that express LH/CG receptors can be targeted and destroyed by
compounds consisting of a lytic peptide moiety and a 15-amino acid segment of
the beta chain of CG. LH/CG receptor capacity was closely correlated with the
toxicity of the targeting lytic peptide-CG conjugates. Data obtained in vitro
established the validity of this concept, showed the strong specificities of the
Hecate-ßCG, and Phor14 and Phor21-ßCG conjugates in killing cells that
express functional LH/CG receptors and proved that the ...
[431]
Surviving Testicular Cancer
[187,4 KB]
From [dissertations.ub.rug.nl] Last viewed: 28.05.2005
Targeted destruction of prostate, breast, ovarian, and testicular
cancer cells through their LH/CG receptors
William Hansel and Carola Leuschner
Pennington Biomedical Research Center, Louisiana State University, Baton
Rouge, LA, 70808
In a series of in vitro and in vivo experiments involving 1630 nude mice, the
concept has been established that prostate, breast, ovarian and testicular cancer
cells that express LH/CG receptors can be targeted and destroyed by
compounds consisting of a lytic peptide moiety and a 15-amino acid segment of
the beta chain of CG. LH/CG receptor capacity was closely correlated with the
toxicity of the targeting lytic peptide-CG conjugates. Data obtained in vitro
established the validity of this concept, showed the strong specificities of the
Hecate-ßCG, and Phor14 and Phor21-ßCG conjugates in killing cells that
express functional LH/CG receptors and proved that the ...
[432]
Surviving Testicular Cancer
[193,5 KB]
From [dissertations.ub.rug.nl] Last viewed: 28.05.2005
Targeted destruction of prostate, breast, ovarian, and testicular
cancer cells through their LH/CG receptors
William Hansel and Carola Leuschner
Pennington Biomedical Research Center, Louisiana State University, Baton
Rouge, LA, 70808
In a series of in vitro and in vivo experiments involving 1630 nude mice, the
concept has been established that prostate, breast, ovarian and testicular cancer
cells that express LH/CG receptors can be targeted and destroyed by
compounds consisting of a lytic peptide moiety and a 15-amino acid segment of
the beta chain of CG. LH/CG receptor capacity was closely correlated with the
toxicity of the targeting lytic peptide-CG conjugates. Data obtained in vitro
established the validity of this concept, showed the strong specificities of the
Hecate-ßCG, and Phor14 and Phor21-ßCG conjugates in killing cells that
express functional LH/CG receptors and proved that the ...
[433]
Surviving Testicular Cancer
[353,9 KB]
From [dissertations.ub.rug.nl] Last viewed: 28.05.2005
Targeted destruction of prostate, breast, ovarian, and testicular
cancer cells through their LH/CG receptors
William Hansel and Carola Leuschner
Pennington Biomedical Research Center, Louisiana State University, Baton
Rouge, LA, 70808
In a series of in vitro and in vivo experiments involving 1630 nude mice, the
concept has been established that prostate, breast, ovarian and testicular cancer
cells that express LH/CG receptors can be targeted and destroyed by
compounds consisting of a lytic peptide moiety and a 15-amino acid segment of
the beta chain of CG. LH/CG receptor capacity was closely correlated with the
toxicity of the targeting lytic peptide-CG conjugates. Data obtained in vitro
established the validity of this concept, showed the strong specificities of the
Hecate-ßCG, and Phor14 and Phor21-ßCG conjugates in killing cells that
express functional LH/CG receptors and proved that the ...
[434]
Surviving Testicular Cancer
[364,4 KB]
From [dissertations.ub.rug.nl] Last viewed: 28.05.2005
Targeted destruction of prostate, breast, ovarian, and testicular
cancer cells through their LH/CG receptors
William Hansel and Carola Leuschner
Pennington Biomedical Research Center, Louisiana State University, Baton
Rouge, LA, 70808
In a series of in vitro and in vivo experiments involving 1630 nude mice, the
concept has been established that prostate, breast, ovarian and testicular cancer
cells that express LH/CG receptors can be targeted and destroyed by
compounds consisting of a lytic peptide moiety and a 15-amino acid segment of
the beta chain of CG. LH/CG receptor capacity was closely correlated with the
toxicity of the targeting lytic peptide-CG conjugates. Data obtained in vitro
established the validity of this concept, showed the strong specificities of the
Hecate-ßCG, and Phor14 and Phor21-ßCG conjugates in killing cells that
express functional LH/CG receptors and proved that the ...
[435]
Surviving Testicular Cancer
[969,7 KB]
From [dissertations.ub.rug.nl] Last viewed: 28.05.2005
Targeted destruction of prostate, breast, ovarian, and testicular
cancer cells through their LH/CG receptors
William Hansel and Carola Leuschner
Pennington Biomedical Research Center, Louisiana State University, Baton
Rouge, LA, 70808
In a series of in vitro and in vivo experiments involving 1630 nude mice, the
concept has been established that prostate, breast, ovarian and testicular cancer
cells that express LH/CG receptors can be targeted and destroyed by
compounds consisting of a lytic peptide moiety and a 15-amino acid segment of
the beta chain of CG. LH/CG receptor capacity was closely correlated with the
toxicity of the targeting lytic peptide-CG conjugates. Data obtained in vitro
established the validity of this concept, showed the strong specificities of the
Hecate-ßCG, and Phor14 and Phor21-ßCG conjugates in killing cells that
express functional LH/CG receptors and proved that the ...
[436]
Surviving Testicular Cancer
[415,4 KB]
From [dissertations.ub.rug.nl] Last viewed: 28.05.2005
Targeted destruction of prostate, breast, ovarian, and testicular
cancer cells through their LH/CG receptors
William Hansel and Carola Leuschner
Pennington Biomedical Research Center, Louisiana State University, Baton
Rouge, LA, 70808
In a series of in vitro and in vivo experiments involving 1630 nude mice, the
concept has been established that prostate, breast, ovarian and testicular cancer
cells that express LH/CG receptors can be targeted and destroyed by
compounds consisting of a lytic peptide moiety and a 15-amino acid segment of
the beta chain of CG. LH/CG receptor capacity was closely correlated with the
toxicity of the targeting lytic peptide-CG conjugates. Data obtained in vitro
established the validity of this concept, showed the strong specificities of the
Hecate-ßCG, and Phor14 and Phor21-ßCG conjugates in killing cells that
express functional LH/CG receptors and proved that the ...
[437]
Surviving Testicular Cancer
[294,6 KB]
From [dissertations.ub.rug.nl] Last viewed: 28.05.2005
Targeted destruction of prostate, breast, ovarian, and testicular
cancer cells through their LH/CG receptors
William Hansel and Carola Leuschner
Pennington Biomedical Research Center, Louisiana State University, Baton
Rouge, LA, 70808
In a series of in vitro and in vivo experiments involving 1630 nude mice, the
concept has been established that prostate, breast, ovarian and testicular cancer
cells that express LH/CG receptors can be targeted and destroyed by
compounds consisting of a lytic peptide moiety and a 15-amino acid segment of
the beta chain of CG. LH/CG receptor capacity was closely correlated with the
toxicity of the targeting lytic peptide-CG conjugates. Data obtained in vitro
established the validity of this concept, showed the strong specificities of the
Hecate-ßCG, and Phor14 and Phor21-ßCG conjugates in killing cells that
express functional LH/CG receptors and proved that the ...
[438]
Surviving Testicular Cancer
[2782,5 KB]
From [dissertations.ub.rug.nl] Last viewed: 28.05.2005
Targeted destruction of prostate, breast, ovarian, and testicular
cancer cells through their LH/CG receptors
William Hansel and Carola Leuschner
Pennington Biomedical Research Center, Louisiana State University, Baton
Rouge, LA, 70808
In a series of in vitro and in vivo experiments involving 1630 nude mice, the
concept has been established that prostate, breast, ovarian and testicular cancer
cells that express LH/CG receptors can be targeted and destroyed by
compounds consisting of a lytic peptide moiety and a 15-amino acid segment of
the beta chain of CG. LH/CG receptor capacity was closely correlated with the
toxicity of the targeting lytic peptide-CG conjugates. Data obtained in vitro
established the validity of this concept, showed the strong specificities of the
Hecate-ßCG, and Phor14 and Phor21-ßCG conjugates in killing cells that
express functional LH/CG receptors and proved that the ...
[439]
Surviving Testicular Cancer
[1138,5 KB]
From [dissertations.ub.rug.nl] Last viewed: 28.05.2005
Targeted destruction of prostate, breast, ovarian, and testicular
cancer cells through their LH/CG receptors
William Hansel and Carola Leuschner
Pennington Biomedical Research Center, Louisiana State University, Baton
Rouge, LA, 70808
In a series of in vitro and in vivo experiments involving 1630 nude mice, the
concept has been established that prostate, breast, ovarian and testicular cancer
cells that express LH/CG receptors can be targeted and destroyed by
compounds consisting of a lytic peptide moiety and a 15-amino acid segment of
the beta chain of CG. LH/CG receptor capacity was closely correlated with the
toxicity of the targeting lytic peptide-CG conjugates. Data obtained in vitro
established the validity of this concept, showed the strong specificities of the
Hecate-ßCG, and Phor14 and Phor21-ßCG conjugates in killing cells that
express functional LH/CG receptors and proved that the ...
[440]
Acral Necrosis after Inadequate Excessive Administration of ...
[7,6 KB]
From [content.karger.com] Last viewed: 28.05.2005
Essay
Testicular cancer is most commonly found in adolescents or young
adults. To any young man in my situation, I would highly recommend the
book, It's Not About the Bike My Journey Back to Life by Lance
Armstrong.
One of the keys to physical, mental, and emotional survival during
cancer treatment is maintaining a positive outlook. A cancer patient needs a
positive attitude and a persistent hope that health will be restored and the
cancer will be defeated. In this way, Lance Armstrong's story is an excellent
motivator. Lance not only had cancer in the testicle but it had spread
throughout his body. He had surgery and chemotherapy. His was just about
the worst possible scenario with the best possible outcome. Reading his
story gives a cancer patient hope that he, too, can overcome the many
obstacles of cancer , no matter how bad things look at the beginning.
Lance is a great ...
[441]
Follow-Up of Testicular Microlithiasis for Subsequent Testicular ...
[7,6 KB]
From [content.karger.com] Last viewed: 28.05.2005
Essay
Testicular cancer is most commonly found in adolescents or young
adults. To any young man in my situation, I would highly recommend the
book, It's Not About the Bike My Journey Back to Life by Lance
Armstrong.
One of the keys to physical, mental, and emotional survival during
cancer treatment is maintaining a positive outlook. A cancer patient needs a
positive attitude and a persistent hope that health will be restored and the
cancer will be defeated. In this way, Lance Armstrong's story is an excellent
motivator. Lance not only had cancer in the testicle but it had spread
throughout his body. He had surgery and chemotherapy. His was just about
the worst possible scenario with the best possible outcome. Reading his
story gives a cancer patient hope that he, too, can overcome the many
obstacles of cancer , no matter how bad things look at the beginning.
Lance is a great ...
[442]
Testicular Function after Cancer Treatment in Childhood
[7,6 KB]
From [content.karger.com] Last viewed: 28.05.2005
Essay
Testicular cancer is most commonly found in adolescents or young
adults. To any young man in my situation, I would highly recommend the
book, It's Not About the Bike My Journey Back to Life by Lance
Armstrong.
One of the keys to physical, mental, and emotional survival during
cancer treatment is maintaining a positive outlook. A cancer patient needs a
positive attitude and a persistent hope that health will be restored and the
cancer will be defeated. In this way, Lance Armstrong's story is an excellent
motivator. Lance not only had cancer in the testicle but it had spread
throughout his body. He had surgery and chemotherapy. His was just about
the worst possible scenario with the best possible outcome. Reading his
story gives a cancer patient hope that he, too, can overcome the many
obstacles of cancer , no matter how bad things look at the beginning.
Lance is a great ...
[443]
Testicular Function after Cancer Treatment in Childhood
[0,3 KB]
From [content.karger.com] Last viewed: 28.05.2005
Essay
Testicular cancer is most commonly found in adolescents or young
adults. To any young man in my situation, I would highly recommend the
book, It's Not About the Bike My Journey Back to Life by Lance
Armstrong.
One of the keys to physical, mental, and emotional survival during
cancer treatment is maintaining a positive outlook. A cancer patient needs a
positive attitude and a persistent hope that health will be restored and the
cancer will be defeated. In this way, Lance Armstrong's story is an excellent
motivator. Lance not only had cancer in the testicle but it had spread
throughout his body. He had surgery and chemotherapy. His was just about
the worst possible scenario with the best possible outcome. Reading his
story gives a cancer patient hope that he, too, can overcome the many
obstacles of cancer , no matter how bad things look at the beginning.
Lance is a great ...
[444]
Laparoscopic retroperitoneal lymphadenectomy in the management of ...
[21,5 KB]
From [taylorandfrancis.metapress.com] Last viewed: 28.05.2005
TESTICULAR CANCER
What Is Cancer ?
Cancer is a group of many related diseases. All forms of cancer involve out-of-control growth
and spread of abnormal cells.
Normal body cells grow, divide, and die in an orderly fashion. During the early years of a
person's life, normal cells divide more rapidly until the person becomes an adult. After that,
normal cells of most tissues divide only to replace worn-out or dying cells and to repair injuries.
Cancer cells, however, continue to grow and divide, and can spread to other parts of the body.
These cells accumulate and form tumors (lumps) that may compress, invade, and destroy normal
tissue. If cells break away from such a tumor, they can travel through the bloodstream, or the
lymph system to other areas of the body. There, they may settle and form "colony" tumors. In
their new location, the cancer cells continue growing. The spread of a ...
[445]
Metastatic testicular cancer and extragonadal germ cell tumor ...
From [www.springerlink.com] Last viewed: 28.05.2005
Overview:
Testicular cancer is the most common form of cancer in men between age 20 and 34; it accounts for 19% of all cancers in
that age group. In the 1990s, somewhere between 6,000 and 7,000 testicular cancers were diagnosed each year. Due to
frequent early diagnosis, testicular cancer is often removed before it has the chance to metastasize (spread beyond the
area of origin). Approximately 350 deaths occur annually as a result of testicular cancer and related complications.
Different cell types are found in testicular cancers. The most common form of testicular cancer are germ cell cancers
(both seminomas and nonseminomas ) accounting for 95% of the condition. Non-germ cell testicular cancers come from a
variety of cell types, some of which may originate from other malignancies, such as lymphoma.
Diagnostic procedures include blood and urine studies. Other procedures ...
[446]
Complications of primary retroperitoneal lymph-node dissection for ...
From [www.springerlink.com] Last viewed: 28.05.2005
Overview:
Testicular cancer is the most common form of cancer in men between age 20 and 34; it accounts for 19% of all cancers in
that age group. In the 1990s, somewhere between 6,000 and 7,000 testicular cancers were diagnosed each year. Due to
frequent early diagnosis, testicular cancer is often removed before it has the chance to metastasize (spread beyond the
area of origin). Approximately 350 deaths occur annually as a result of testicular cancer and related complications.
Different cell types are found in testicular cancers. The most common form of testicular cancer are germ cell cancers
(both seminomas and nonseminomas ) accounting for 95% of the condition. Non-germ cell testicular cancers come from a
variety of cell types, some of which may originate from other malignancies, such as lymphoma.
Diagnostic procedures include blood and urine studies. Other procedures ...
[447]
Targeted destruction of prostate, breast, ovarian, and testicular ...
[35,5 KB]
From [www.bmb.uga.edu] Last viewed: 16.04.2005
Targeted destruction of prostate, breast, ovarian, and testicular
cancer cells through their LH/CG receptors
William Hansel and Carola Leuschner
Pennington Biomedical Research Center, Louisiana State University, Baton
Rouge, LA, 70808
In a series of in vitro and in vivo experiments involving 1630 nude mice, the
concept has been established that prostate, breast, ovarian and testicular cancer
cells that express LH/CG receptors can be targeted and destroyed by
compounds consisting of a lytic peptide moiety and a 15-amino acid segment of
the beta chain of CG. LH/CG receptor capacity was closely correlated with the
toxicity of the targeting lytic peptide-CG conjugates. Data obtained in vitro
established the validity of this concept, showed the strong specificities of the
Hecate-ßCG, and Phor14 and Phor21-ßCG conjugates in killing cells that
express functional LH/CG receptors and proved that the ...
[448]
(Dis)embodying gender and sexuality in testicular cancer
[166,8 KB]
From [www.ryerson.ca] Last viewed: 16.04.2005
Social Science & Medicine 58 (2004) 1597–1607
(Dis)embodying gender and sexuality in testicular cancer
Maria Gurevich
a,
*, Scott Bishop
b
, Jo Bower
c
, Monika Malka
d
,
Joyce Nyhof-Young
e
a
Department of Psychology, Ryerson University and Psychosocial Oncology and Palliative Care Program, Princess Margaret Hospital,
University Health Network, 350 Victoria Street, Toronto, Ont., Canada M5B 2K3
b
Psychological Trauma Program, Centre for Addiction and Mental Health, and Department of Psychiatry, University of Toronto,
Canada
c
Communications and Psychology Research Consulting, Canada
d
Circle of Care and Jewish Hospice Programs, Canada
e
Department of Radiation Oncology, University of Toronto, Princess Margaret Hospital, University Health Network, Canada ...
[449]
Molecular analysis of androgen receptor gene in testicular cancer
[350,7 KB]
From [journals.endocrinology.org] Last viewed: 16.04.2005
ACCEPTED PREPRINT
Molecular analysis of androgen receptor gene in testicular cancer
Short title: Androgen receptor gene in testicular cancer
A. Garolla
1
, A. Ferlin
1
, C. Vinanzi
1
, A. Roverato
2
, G. Sotti
3
, W. Artibani
4
and C. Foresta
1
1
University of Padova, Department of Histology, Microbiology and Medical Biotechnologies, Centre for Male
Gamete Cryopreservation, Padova, Italy
2
University of Modena and Reggio Emilia, Department of Social, Cognitive and Quantitative Sciences, Modena,
Italy
3
University of Padova, Department of Radiotherapy and Nuclear Medicine, Padova, Italy
4
University of Padova, Department of Oncological and Surgical Sciences, Padova, Italy
Corresponding author and ...
[450]
what is testicular cancer? signs and symptoms what happens next ...
[264,2 KB]
From [www.keepyoureyeontheball.org] Last viewed: 16.04.2005
what is testicular
cancer ?
signs and
symptoms
what happens
next?
the future
Testicular cancer is the most common cancer to affect men
between 20-35 years old.
The incidence of testicular cancer has almost doubled in the past
20 years and currently about 2,000 new cases are diagnosed
each year.
According to a MORI poll carried out by The Institute of
Cancer Research, only 14% of young men check their testicles
regularly. Yet this method of early detection is both simple
and effective.
Thanks to advances made at The Institute, testicular cancer is
easily treated if caught at an early stage and is nearly always
curable. If diagnosed early enough the recovery rate
can be as high as 96%.
But we urgently need to find out what causes testicular cancer
and why cases are increasing so dramatically.
Regular ...